Browsing by Author "Hasegawa, Kosei"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item ENGOT-en9/LEAP-001: A phase III study of first-line pembrolizumab plus lenvatinib versus chemotherapy in advanced or recurrent endometrial cancer.(2020) Marth, Christian; Vulsteke, Christof; Perez, Maria Jesus Rubio; Makker, Vicky; Braicu, Elena Ioana; McNeish, Iain A.; Madry, Radoslaw; Ayhan, Ali; Hasegawa, Kosei; Wu, Xiaohua; Dutta, Lea; Xu, Cindy; Keefe, Stephen Michael; Lee, John J.; Pignata, SandroItem ENGOT-ov65/KEYNOTE-B96: Phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer(2022) Colombo, Nicoletta; Coleman, Robert L.; Wu, Xiaohua; Kose, Fatih; Wenham, Robert Michael; Sebastianelli, Alexandra; Hasegawa, Kosei; Zsiros, Emese; Rouge, Thibault De la Motte; Bidzinski, Mariusz; McNeish, Iain A.; Sehouli, Jalid; Korach, Jacob; Debruyne, Philip R.; Kim, Jae-Weon; De Melo, Andrea C.; Peng, Xuan; Bogusz, Agata M.; Yamada, Karin Sayuri; Monk, Bradley J.